Almost all of the oxygen consumed by the brain is 
							utilized for the oxidation of carbohydrate. 
							Sufficient energy is released from this process so 
							that the normal level of oxygen utilization is 
							adequate to replace the 12 mmol or so of A TP which 
							the whole brain uses per minute. However, since the 
							normal brain reserve of A TP and creatine phosphate 
							(CrP) totals only about 8 rnmol, less than a 
							minute's reserve of high energy phosphate bonds is 
							actually available if production were to suddenly 
							stop. In the absence of oxygen, the anerobic 
							glycolysis of glucose and glycogen could supply only 
							another 15 mmol of A TP, as these two energy 
							substrates are stored in such low quantities in 
							brain tissue. 
							
							
							A continuous uninterrupted supply of oxygen to the 
							brain is essential in order to maintain its 
							metabolic functions and to prevent tissue damage. 
							The oxygen-independent glycolytic pathway (anerobic 
							glycolysis) is insufficient, even at maximum 
							operating levels, to supply the heavy demands of the 
							brain. Thus a loss of consciousness occurs when 
							brain tissue P02 levels fall to 15 to
							
							
							20 
							
							mmHg. This level is reached in less than 
							
							10 
							
							s when cerebral blood flow is completely stopped
							
							
							
							Low tissue oxygen levels in the brain (hypoxidosis) 
							can be caused by decreased blood flow (ischemia) or 
							with adequate blood flow accompanied by low levels 
							of blood oxygen (hypoxemia). It is important to 
							recognize that decreased P02 caused by 
							ischemia is accompanied by decreased brain glucose 
							and increased brain CO2 while hypoxemia 
							with normal blood flow is not accompanied by changes 
							in brain glucose or CO2,
							with 
							complete cessation of CBF, irreversible damage 
							occurs to brain tissue within a few minutes and the 
							histological effects observed are remarkably 
							similar whether caused by ischemia, hypoxemia, or 
							hypoglycemia. 
							
							
							Experimental studies on rats and mice in which 
							arterial P02 is progressively reduced 
							have illustrated some aspects of hypoxemia which are 
							likely to be similar in humans. A drop in arterial 
							P02
							
							
							to 50 mmHg (normal, 96 mmHg) produces no change in 
							CBF, O2
							
							
							utilization by the brain, or lactic acid 
							production. However, as P02
							
							
							levels drop to 30 mmHg, a 50 percent increase in CBF 
							is observed along with the onset of coma, decreased 
							oxygen utilization, and increased lactic acid 
							production. When the P02 drops further to 
							15 mmHg, 50 percent of the animals die because of 
							cardiac failure. The remainder show a tremendous 
							increase in lactic acid production, but, 
							surprisingly, levels of ATP, ADP, and AMP remain 
							normal. If cerebral perfusion is artificially 
							maintained while the arterial P02
							
							
							is decreased further, ATP, ADP, and AMP levels still 
							remain normal. The implication is that the coma 
							observed at low oxygen levels may not be due to a 
							decrease in ATP but instead to some still 
							unexplained mechanism. It appears likely that 
							cardiac complications caused by hypoxemia and the 
							subsequent effect on cerebral blood flow may 
							actually be a primary cause of the irreversible 
							pathologic damage to the brain. 
							
							
							Hypoxia, such as that brought on by high altitudes, 
							brings on a number of symptoms, including 
							drowsiness, apathy, and decreases in judgment. 
							Unless oxygen is administered within half a minute 
							or so, coma, convulsions, and depression of the EEG 
							occur.